Literature DB >> 25326101

Screening in asymptomatic coronary artery disease: helpful, redundant or harmful?

E E van der Wall1.   

Abstract

Entities:  

Year:  2014        PMID: 25326101      PMCID: PMC4391182          DOI: 10.1007/s12471-014-0614-0

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


× No keyword cloud information.
Screening asymptomatic individuals remains the subject of intense debate in medicine. In the beginning of 2014 the use of screening for breast cancer in women was seriously questioned based on studies from Canada (Toronto) and the Netherlands (Leiden). It was shown that, particularly in women over 70 years, screening for breast cancer might even bring more harm than benefit in terms of over diagnosis and thus overtreatment. With respect to carotid artery disease, in September of this year the United States Preventive Services Task Force (USPSTF) published a recommendation to oppose the screening of the general adult population to detect asymptomatic carotid artery stenosis [1]. The Task Force found that ultrasound may produce false-positives resulting in angiography or even surgery, with the accompanying high risk of stroke, heart attack, or death. This recommendation may be important because it may influence insurance coverage. How about screening individuals with asymptomatic coronary artery disease? In a review article from the Netherlands (Rotterdam) a systematic review of guidelines on imaging of asymptomatic coronary artery disease showed the light in 2011 [2]. It turned out that guideline on risk assessment by imaging of asymptomatic coronary artery disease contained conflicting recommendations. Out of the 14 guidelines that met the inclusion criteria, eight guidelines recommended against or found insufficient evidence for testing individuals with asymptomatic coronary artery disease. The authors suggested therefore that more research, including randomized controlled trials, is needed to evaluate the impact of imaging on clinical outcomes and costs. Over the past years cardiac computed tomography (CT) has emerged as a screening tool - in addition to the proven use of major risk factors - to detect coronary artery disease in an early stage of its process [3-7]. Both calcium scoring and coronary CT angiography have been shown useful to identify coronary artery lesions. However, how does one manage the issue of using coronary CT as a screening test in asymptomatic individuals? According to the 2013 ESC Guidelines on Stable Angina Pectoris [8], both coronary calcium detection by CT and coronary CT angiography receive a Class III indication, meaning that there is ‘evidence and/or general agreement that the procedure is not useful/effective and in some cases may be harmful’. The inherent guideline recommendations were twofold: 1) coronary calcium detection by CT is not recommended to identify individuals with coronary artery disease, and 2) coronary CT angiography is not recommended as a screening test in asymptomatic individuals without clinical suspicion of coronary artery disease. Apart from the lack of usefulness of applying CT in asymptomatic individuals one should always be aware of the risk of radiation exposure using ionising imaging modalities to detect patients with coronary artery disease. To that purpose, the American Heart Association (AHA) very recently issued a scientific statement on cardiac imaging, published online on 29 September 2014 in the journal Circulation [9]. The AHA scientific statement recommended that exposure to radiation should be part of the discussion on cardiac imaging for both referring and performing physicians. Physicians should be required to know which cardiac imaging tests use ionising radiation, understand the basics of exposure, and know the typical dose estimates for the most commonly used cardiac imaging procedures. In addition, they should counsel patients on the risks as well as on potential benefits so that patients can give truly informed consent. Consequently, before referring a patient for a cardiac imaging test, the AHA recommends that physicians address important questions such as 1) how will the test help diagnose or treat the cardiac problem, 2) are there alternative modalities not using radiation, 3) what are the levels of radiation exposure, 4) how will it affect the risk of cancer later in life, and 5) how does that compare with the risk from other common activities. These questions remain pertinent despite successful technological attempts to reduce radiation exposure, which holds in particular for cardiac CT. To conclude, although screening for coronary artery disease -especially using advanced ionising cardiac imaging techniques [10] - may be helpful in patients with a intermediate to high probability of disease, it may be redundant in patients with a low prevalence of disease and even harmful in asymptomatic individuals.
  10 in total

1.  Approaches to enhancing radiation safety in cardiovascular imaging: a scientific statement from the American Heart Association.

Authors:  Reza Fazel; Thomas C Gerber; Stephen Balter; David J Brenner; J Jeffrey Carr; Manuel D Cerqueira; Jersey Chen; Andrew J Einstein; Harlan M Krumholz; Mahadevappa Mahesh; Cynthia H McCollough; James K Min; Richard L Morin; Brahmajee K Nallamothu; Khurram Nasir; Rita F Redberg; Leslee J Shaw
Journal:  Circulation       Date:  2014-09-29       Impact factor: 29.690

2.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

Authors:  Gilles Montalescot; Udo Sechtem; Stephan Achenbach; Felicita Andreotti; Chris Arden; Andrzej Budaj; Raffaele Bugiardini; Filippo Crea; Thomas Cuisset; Carlo Di Mario; J Rafael Ferreira; Bernard J Gersh; Anselm K Gitt; Jean-Sebastien Hulot; Nikolaus Marx; Lionel H Opie; Matthias Pfisterer; Eva Prescott; Frank Ruschitzka; Manel Sabaté; Roxy Senior; David Paul Taggart; Ernst E van der Wall; Christiaan J M Vrints; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Juhani Knuuti; Marco Valgimigli; Héctor Bueno; Marc J Claeys; Norbert Donner-Banzhoff; Cetin Erol; Herbert Frank; Christian Funck-Brentano; Oliver Gaemperli; José R Gonzalez-Juanatey; Michalis Hamilos; David Hasdai; Steen Husted; Stefan K James; Kari Kervinen; Philippe Kolh; Steen Dalby Kristensen; Patrizio Lancellotti; Aldo Pietro Maggioni; Massimo F Piepoli; Axel R Pries; Francesco Romeo; Lars Rydén; Maarten L Simoons; Per Anton Sirnes; Ph Gabriel Steg; Adam Timmis; William Wijns; Stephan Windecker; Aylin Yildirir; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2013-08-30       Impact factor: 29.983

3.  Is cardiac CT a reproducible alternative for cardiac MR in adult patients with a systemic right ventricle?

Authors:  M M Winter; S Romeih; B J Bouma; M Groenink; N A Blom; A M Spijkerboer; B J M Mulder
Journal:  Neth Heart J       Date:  2012-11       Impact factor: 2.380

4.  CT fractional flow reserve: the next level in non-invasive cardiac imaging.

Authors:  M F L Meijs; M J Cramer; H El Aidi; P A Doevendans
Journal:  Neth Heart J       Date:  2012-10       Impact factor: 2.380

Review 5.  Systematic review of guidelines on imaging of asymptomatic coronary artery disease.

Authors:  Bart S Ferket; Tessa S S Genders; Ersen B Colkesen; Jacob J Visser; Sandra Spronk; Ewout W Steyerberg; M G Myriam Hunink
Journal:  J Am Coll Cardiol       Date:  2011-04-12       Impact factor: 24.094

Review 6.  Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Authors:  Daniel E Jonas; Cynthia Feltner; Halle R Amick; Stacey Sheridan; Zhi-Jie Zheng; Daniel J Watford; Jamie L Carter; Cassandra J Rowe; Russell Harris
Journal:  Ann Intern Med       Date:  2014-09-02       Impact factor: 25.391

7.  Cost analysis favours SPECT over PET and CTA for evaluation of coronary artery disease: the SPARC study.

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2014-06       Impact factor: 2.380

8.  Crown years for non-invasive cardiovascular imaging (Part IV): 30 years of cardiac computed tomography.

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2013-07       Impact factor: 2.380

9.  Different value of coronary calcium score to predict obstructive coronary artery disease in patients with and without moderate chronic kidney disease.

Authors:  K H Yiu; F R de Graaf; J E van Velzen; N A Marsan; C J Roos; M K de Bie; H F Tse; E E van der Wall; M J Schalij; J J Bax; J D Schuijf; J W Jukema
Journal:  Neth Heart J       Date:  2013-07       Impact factor: 2.380

10.  Coronary CT angiography in the elderly.

Authors:  R Nijveldt; T Pflederer; S Achenbach
Journal:  Neth Heart J       Date:  2014-03       Impact factor: 2.380

  10 in total
  1 in total

1.  Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis.

Authors:  Chia-Chi Hsiao; Pai-Hsueh Teng; Yun-Ju Wu; Yi-Wen Shen; Guang-Yuan Mar; Fu-Zong Wu
Journal:  BMC Cardiovasc Disord       Date:  2021-05-19       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.